in

PCOS and Metabolic Health: Latest Research and Treatments in 2026

Medically Reviewed & Fact-Checked
By Dr. Ahmed Farhan, MBBS, FCPS (Assistant Professor of Medicine)
Updated:

Medical Disclaimer: This article is for educational and informational purposes only and does not constitute individual medical advice, diagnosis, or clinical treatment. Always consult your personal physician or qualified healthcare provider regarding medical conditions, prescription changes, or new health regimens.

Transparency Disclosure: Dibesity features independent, evidence-based medical research. Some articles may contain vetted affiliate links to metabolic wellness products; if you make a purchase, we may earn a modest commission at no extra cost to you.

PCOS/ PMOS:

Polycystic ovary syndrome, usually called PCOS, is one of the most common hormone conditions in women of reproductive age.

It is often discussed in terms of periods, fertility, and skin or hair changes. Increasingly, however, researchers are also studying how PCOS affects the body’s use of sugar and fat, and how it relates to long-term heart and liver health.

This article draws on four recent or published studies: two 2025 reviews in the journal Reproduction, a 2025 narrative review in Global Reproductive Health, and a 2022 case-control study from Turkey.

Together, they offer a useful picture of the current thinking. The authors of these works were working from published evidence, and this article summarizes their abstracts and the findings described in them. It does not replace reading the full papers.

What Is PCOS?

PCOS is a hormonal condition that affects how the ovaries work. Women with PCOS often have higher levels of androgens, which are sometimes called male hormones.

Every woman’s body makes small amounts of androgens, so the key question is whether levels are high enough to cause symptoms. This is known as androgen excess, or hyperandrogenism.

In practice, PCOS can cause irregular periods, difficulty ovulating (releasing an egg), and signs of androgen excess such as acne or excess hair growth.

Doctors diagnose it using established criteria, and there is no single test that defines it. Because of this, reported rates differ between studies.

One review cites a prevalence of about 12% among women, while another reports a range of 5% to 20% among premenopausal women worldwide. These differences partly reflect how the condition is defined and who is studied.

Why Does It Matter?

For many years, PCOS was viewed mainly as a fertility issue. The newer research describes it as a condition that also involves metabolism, the set of processes that turn food into energy and store or use fat and sugar. Metabolic health includes blood sugar control, body fat distribution, cholesterol, and liver function.

This wider view matters because metabolic problems can affect health across a lifetime, not just during the years when a woman is trying to conceive. Understanding these links may help clinicians think about PCOS as a long-term condition.

What Does the Latest Research Show?

Obesity and PCOS influence each other

The 2025 narrative review by Teede and Tay describes a two-way relationship between body weight and PCOS. Higher body mass index (BMI) is linked with a greater chance of developing PCOS.

At the same time, PCOS is linked with a higher risk of weight gain. The authors report that Mendelian randomization studies, a type of genetic analysis that helps test cause and effect, support causal links in both directions.

The review also suggests that higher BMI can make PCOS more severe. It may increase androgen levels and insulin resistance, which in turn can affect ovulation, fertility, and pregnancy.

Importantly, the authors describe these findings as part of a broader picture. Genetic studies strengthen the case for causation, but many questions about how much weight changes affect PCOS over time are still being studied.

Androgens and metabolic disease

A second 2025 review by Cussen and colleagues focuses on the role of androgens in metabolism.

The authors describe how androgen excess may contribute to insulin resistance, a state in which the body’s cells respond less well to insulin, the hormone that helps move sugar from the blood into cells. Insulin resistance can lead to type 2 diabetes over time.

According to this review, androgen excess may also promote increased visceral fat, which is fat stored deep in the abdomen around organs.

It may affect how fat cells work, how muscle responds to insulin, and how fat builds up in the liver. The authors describe a cycle in which insulin resistance and androgen excess can reinforce each other.

The review notes that epidemiological and laboratory studies support a causal link between hyperandrogenism and type 2 diabetes, even when body weight is taken into account.

This is an important point, because it suggests that androgens may matter for blood sugar control beyond their link with obesity.

However, the review also notes that the role of 11-oxygenated androgens, a group of androgens made through peripheral tissues, is an emerging area that still needs more study.

Heart health over the long term

The 2025 review by Dokras, Luque-Ramírez, and Escobar-Morreale looks at long-term outcomes. Cardiovascular risk factors such as high blood pressure, high cholesterol, and insulin resistance can cluster in women with PCOS, even when they are young adults.

Some systematic reviews suggest that middle-aged and postmenopausal women with PCOS may have a higher risk of heart attack and stroke compared with women without hyperandrogenism.

However, the authors emphasize that obesity appears to explain much of this association. When women with PCOS are compared with women without PCOS who have a similar body weight, the cardiovascular risk appears similar.

The review also mentions a longitudinal cohort study that followed Caucasian women with PCOS for 10 years and did not find increased cardiovascular events in the late reproductive or early postmenopausal period, even though risk factors were common.

The authors conclude that the long-term outlook may be better than the cardiometabolic risk factors alone would suggest, provided obesity is avoided and the condition is well managed.

Diet and acid load: a smaller, unresolved question

A 2022 case-control study from Turkey examined whether dietary acid load, a measure of how a diet affects the body’s acid-base balance, is related to metabolic status in PCOS.

The researchers compared 46 newly diagnosed women with PCOS and 46 healthy women matched for age and BMI. Diet was recorded over three days and analyzed using two standard scores, NEAP and PRAL.

The study found no statistically significant difference in either acid load score between the two groups. Women with PCOS did, however, have higher fasting insulin levels and higher HOMA-IR, a common measure of insulin resistance.

The authors concluded that dietary acid load did not appear to explain the metabolic differences in this group. Because the study was small and based on a single location, it should be seen as one piece of a larger, unfinished picture.

How Does It Work?

The research points to a few interacting processes. Androgen excess may change how fat is stored, pushing it toward the abdomen and into the liver.

Fat tissue may become less healthy, releasing substances linked with low-grade inflammation. Muscle tissue may respond less well to insulin, so more sugar stays in the blood. Over time, these changes can add to one another.

Obesity can intensify these processes, and insulin resistance can in turn encourage the ovaries to produce more androgens.

This two-way loop helps explain why researchers talk about a self-perpetuating cycle. It is best understood as a model supported by a body of research rather than a fully settled explanation.

Who May Benefit or Be Affected?

The evidence described above is most relevant to women with PCOS, particularly those with signs of androgen excess, higher body weight, or insulin resistance.

Some research suggests that hyperandrogenic forms of PCOS may carry greater cardiovascular concern, though the evidence on this point is still debated.

Clinicians also note that PCOS can affect mental health, partly because of symptoms such as unwanted hair growth and changes in weight.

Women with PCOS and their families may find it helpful to discuss emotional well-being alongside physical health. Anyone who recognizes these symptoms should speak with a healthcare professional for an individual assessment.

Practical Implications

The most consistent message across these studies is that body weight and metabolic health are closely connected in PCOS.

The International PCOS Guideline, as described in the Teede and Tay review, emphasizes life-course management. This includes lifestyle changes, medication where appropriate, and in some cases surgery, with care planned across different stages of life.

For general readers, a few broad ideas stand out. Regular check-ups can help track blood pressure, blood sugar, and cholesterol.

Lifestyle habits such as regular physical activity and balanced eating are commonly recommended in PCOS care, although the research summarized here does not identify a single best diet.

Clinicians tailor these recommendations to each person, and the studies discussed do not provide individual advice.

Risks, Limitations, and Uncertainties

Several limitations are important. First, all four sources were reviewed through their abstracts. This article does not describe full methods, complete data tables, or every subgroup analysis.

Second, two of the sources are narrative reviews, which summarize existing studies but do not follow a single standardized method. Third, the Turkish study was small and compared only two groups, so it cannot establish causes.

The biggest uncertainty concerns cause and effect. Many findings are observational, meaning they show that certain factors occur together.

Genetic studies offer stronger support for causation in some areas, but they do not answer every question.

The long-term cardiovascular data come mainly from specific populations, including a cohort of Caucasian women, so results may not apply equally to everyone. The role of newer androgens such as 11-oxygenated androgens remains an emerging area.

Readers should also be cautious about headlines that describe PCOS as either deadly or harmless. The evidence points to a condition with real metabolic implications that are shaped by weight, age, and management, but it does not support fear-based conclusions.

Frequently Asked Questions

Does PCOS cause obesity, or does obesity cause PCOS?

Both directions appear to occur. Research summarized by Teede and Tay describes a bidirectional relationship, with genetic studies supporting causal links in each direction. Researchers are still working out how much each factor contributes.

Is insulin resistance always present in PCOS?

No. The Turkish study found higher fasting insulin and HOMA-IR in women with PCOS compared with matched controls, but insulin resistance does not occur in every person with PCOS. It is a common and important feature that clinicians may evaluate.

Does having PCOS mean a higher heart attack risk later in life?

Some systematic reviews suggest a possible increase in cardiovascular events in middle-aged and postmenopausal women with PCOS.

However, when women are matched for weight, the risk appears similar to that of women without PCOS.

A 10-year cohort study did not find increased events during the late reproductive or early postmenopausal period. Overall, the outlook appears better than the risk factors alone might suggest, but ongoing monitoring is still recommended.

Does diet acid load explain the metabolic problems in PCOS?

Not based on the current evidence. The 2022 study did not find a difference in acid load scores between women with and without PCOS. This is a single small study, so it should not be treated as the final word on diet and PCOS.

Can PCOS be cured?

The approved research does not describe a cure. The focus of current guidance is on managing symptoms and reducing long-term metabolic and cardiovascular risks.

Key Takeaways

PCOS is a hormone condition that involves more than fertility. Androgen excess, insulin resistance, and body weight appear to interact in ways that affect metabolic health.

Obesity plays a major role in many of the cardiovascular associations, and avoiding obesity and managing PCOS are highlighted as important goals.

Some areas, including the exact role of newer androgens and the best approach to diet, remain under study. Regular medical follow-up is a sensible step for women with PCOS.

Medical disclaimer: This article is for general educational purposes only and is not medical advice. It is based on abstracts of the cited studies and has not been independently verified against full texts. Anyone with concerns about PCOS, metabolic health, or heart health should consult a qualified healthcare professional.

References

  1. POLYCYSTIC OVARY SYNDROME: ORIGINS AND IMPLICATIONS: Polycystic ovary syndrome: the impact of androgen excess on metabolic health. DOI: https://doi.org/10.1530/rep-25-0102
  2. Polycystic ovary syndrome: A female endocrine metabolic reproductive syndrome in the context of rising global obesity. DOI: https://doi.org/10.1097/grh.0000000000000122
  3. POLYCYSTIC OVARY SYNDROME: ORIGINS AND IMPLICATIONS: Long-term health outcomes in polycystic ovary syndrome. DOI: https://doi.org/10.1530/rep-25-0118
  4. Metabolic status is not related to dietary acid load in polycystic ovary syndrome. DOI: https://doi.org/10.20492/aeahtd.1069778

Recommended Metabolic Health & Wellness Products

A curated index of metabolic support compounds, prebiotic fibres, functional botanicals, and zero-sugar pantry staples selected for ingredient quality and scientific relevance.

Editorial Integrity & Medical Disclaimer: All content on Dibesity.com is created for educational and informational purposes. Product listings do not constitute medical advice, disease management protocols, or an endorsement of specific health outcomes. Always consult your qualified healthcare provider before introducing new nutritional supplements.

Transparency Notice: As an Amazon Associate, Dibesity.com earns from qualifying purchases made through external affiliate links, at no extra cost to you.

Targeted Metabolic & Cellular Support

Apigenin Powder

A bioflavonoid compound explored for cellular protection, circadian rhythm support, and metabolic balance.

View on Amazon →

97% Pure Berberine Powder (100 g)

High-purity berberine HCl powder for customizable serving sizes and metabolic pathway support.

View on Amazon →

Berberine Powder (200 g)

Bulk berberine powder formulation. Check the listing for ingredient details, certificates of analysis, and reviews.

View on Amazon →

Pure Inositol Powder

Pure Myo-Inositol and D-Chiro-Inositol powder formulation for metabolic and reproductive wellness. Check the listing for details.

View on Amazon →

Functional Botanicals & Prebiotic Fibres

Psyllium Husk with Fennel & Cardamom

A soluble prebiotic fibre blend with warming digestive spices to support gut motility and postprandial glucose moderation.

View on Amazon →

100% Pure Hibiscus Powder

Anthocyanin-rich botanical powder supporting cardiometabolic markers, nitric oxide pathways, and vascular health.

View on Amazon →

Roasted Barley Powder

A roasted whole-grain grain alternative suitable for nutritious, caffeine-free herbal teas and warm beverages.

View on Amazon →

Allulose Confectionery (Low-Glycaemic)

Strawberry Allulose Gummies

Low-calorie, rare-sugar allulose gummies designed to satisfy sweet cravings without causing glycemic spikes.

View on Amazon →

Watermelon Allulose Gummies

Refreshing watermelon flavour sweetened with keto-compatible allulose. Minimal net impact on blood sugar.

View on Amazon →

Mixed Berry Allulose Gummies

Berry-flavoured chewable treats sweetened with rare sugar allulose for a clean, tooth-friendly profile.

View on Amazon →

Compliance Note: As an Amazon Associate, Dibesity.com earns from qualifying purchases. Prices, packaging, and availability are set directly by Amazon and participating retailers and are subject to change. Please verify current specifications and allergen warnings on the merchant listing before purchasing.

What do you think?

Written by Dr. Ahmed Farhan


Dr. Ahmed Farhan

MBBS, FCPS (Internal Medicine) | Assistant Professor of Medicine

| Consultant Physician | Specialist in Diabetes, Weight Management & Lifestyle Medicine

Founder of Dibesity | Advocate of Evidence-Based Natural Health

2026 Migraine Prevention Plan Medium

Migraine Prevention in 2026: New Evidence and Access Gaps